The marker of adverse prognosis 1.5-anhydroglucitol in patients with coronary heart disease in the long-term period after planned myocardial revascularization - PDF (Russian)
Copyright (c) 2019 Consilium Medicum

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.